Zhang, Yufei <br/><br/>
Systemic injection of TLR1/2 agonist improves adoptive antigen-specific T cell therapy in glioma-bearing mice.  [electronic resource] 

 -  Clinical immunology (Orlando, Fla.)  Sep 2014 
 - 26-36 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1521-7035 
<br/><br/><label>Standard No.: </label>10.1016/j.clim.2014.06.004  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Brain Neoplasms--therapy<br/>CD8-Positive T-Lymphocytes--transplantation<br/>Cell Proliferation--drug effects<br/>Cell Survival--drug effects<br/>Cell- and Tissue-Based Therapy<br/>Female<br/>Flow Cytometry<br/>Glioma--therapy<br/>Immunotherapy, Adoptive<br/>Lipoproteins--pharmacology<br/>Mice<br/>Mice, Inbred C57BL<br/>Polymerase Chain Reaction<br/>Toll-Like Receptor 1--agonists<br/>Toll-Like Receptor 2--agonists